Proportion of the target population who received the final dose of in Europe and Northern America
Europe and Northern America: Proportion of the target population who received the final dose of was 46.0% in 2024. ▲ Rising
Proportion of the target population who received the final dose of in Europe and Northern America, 2010–2024
Source: United Nations Statistics Division, SDG Global Database.
Analysis
The most recent figure for proportion of the target population who received the final dose of in Europe and Northern America is 46.0%, measured in 2024. That is the highest value across all 15 years on record.
The figure is up 2.2% on the previous year and up 53.3% over ten years.
Over the whole period, proportion of the target population who received the final dose of in Europe and Northern America peaked at 46.0% in 2024 and was at its lowest, 20.0%, in 2010.
Europe and Northern America ranks 16th of 35 groups on this measure, in the middle of the range.
The long-run direction has been consistently rising across the 15 years of available data.
Proportion of the target population who received the final dose of in Europe and Northern America, year by year
| Year | Value | Change |
|---|---|---|
| 2010 | 20.0% | — |
| 2011 | 24.0% | +20.0% |
| 2012 | 25.0% | +4.2% |
| 2013 | 30.0% | +20.0% |
| 2014 | 30.0% | +0.0% |
| 2015 | 32.0% | +6.7% |
| 2016 | 35.0% | +9.4% |
| 2017 | 39.0% | +11.4% |
| 2018 | 37.0% | -5.1% |
| 2019 | 42.0% | +13.5% |
| 2020 | 41.0% | -2.4% |
| 2021 | 42.0% | +2.4% |
| 2022 | 44.0% | +4.8% |
| 2023 | 45.0% | +2.3% |
| 2024 | 46.0% | +2.2% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 31.4% | 20.0% | 42.0% | 10 |
| 2020s | 43.6% | 41.0% | 46.0% | 5 |
Countries ranked near Europe and Northern America
- 14 Brunei Darussalam 88.0% compare
- 14 Brunei Darussalam 88.0% compare
- 16 Chile 87.0% compare
- 16 Sweden 87.0% compare
- 18 Canada 86.0% compare
- 19 Costa Rica 84.0% compare
More infrastructure data for Europe and Northern America
- Proportion of children moderately or severely stunted 3.8% (2024)
- Proportion of children moderately or severely overweight 8.6% (2024)
- Proportion of the target population who received 3 doses of 93.0% (2024)
- Developing countries’ and least developed countries’ share of global 50.9% (2024)
- Developing countries’ and least developed countries’ share of global 47.0% (2024)
- Developing countries’ and least developed countries’ share of global 58.8% (2024)
- Developing countries’ and least developed countries’ share of global 63.5% (2024)
- Proportion of population practicing open defecation, by urban/rural 0.0% (2024)
- Total reserves in months of imports 5.05 (2024)
- Proportion of local breeds classified as being at risk of extinction 83.0% (2025)
Frequently asked questions
- What is proportion of the target population who received the final dose of in Europe and Northern America?
- Proportion of the target population who received the final dose of in Europe and Northern America was 46.0% in 2024, according to United Nations Statistics Division, SDG Global Database.
- What is the highest proportion of the target population who received the final dose of recorded in Europe and Northern America?
- The highest recorded value was 46.0% in 2024.
- What is the lowest proportion of the target population who received the final dose of recorded in Europe and Northern America?
- The lowest recorded value was 20.0% in 2010.
- How does Europe and Northern America rank for proportion of the target population who received the final dose of?
- Europe and Northern America ranks 16th out of 35 groups with data for 2024.
- Is proportion of the target population who received the final dose of rising or falling in Europe and Northern America?
- Over the last ten years it is up 53.3%. The long-run trend across the full record is rising.
- Where does this Europe and Northern America data come from?
- The figures come from United Nations Statistics Division, SDG Global Database, published as part of Proportion of the target population who received the final dose of human papillomavirus (HPV) vaccine (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 15 observations, free to reuse under UN SDG Global Database (open, attribution requested).